Imagion Biosystems Ltd News

Imagion Biosystems CEO Resigns

Imagion Biosystems (ASX:IBX) said Isaac Bright resigned as chief executive, effective Monday, to pursue other opportunities. Chair Bob Proulx will resume operating responsibilities as interim executiv

MT NewswiresJan 15 15:13

Imagion Biosystems Validates Safety, Feasibility of Breast Cancer Imaging Agent in Phase One Trial; Shares Rise 7%

Imagion Biosystems (ASX:IBX) validated the safety and clinical feasibility of the MagSense HER2 imaging agent following results from a phase one clinical trial. The study met its safety and tolerabili

MT NewswiresDec 7, 2023 07:51

Argenica Therapeutics Appoints Nonexecutive Chair

Argenica Therapeutics (ASX:AGN) appointed Dianne Angus as nonexecutive chair, effective Dec. 1, succeeding Geoff Pocock. Angus serves as director of Neuren Pharmaceuticals (ASX:NEU), Cyclopharm (ASX:C

MT NewswiresNov 30, 2023 11:06

Imagion Biosystems Completes Phase 1 Imaging Agent Study

Imagion Biosystems (ASX:IBX) completed its imaging agent phase 1 study for MagSense to help detect human epidermal growth factor receptor 2-positive tumors, according to a Wednesday filing. The trial

MT NewswiresOct 18, 2023 17:49

Imagion Biosystems Secures AU$3.5 Million R&D Tax Rebate for Fiscal Year 2022

Imagion Biosystems (ASX:IBX) secured a AU$3.5 million rebate for the fiscal year ended June 30, 2022 from the Australian government's research and development tax incentive scheme. The refund is highe

MT NewswiresSep 19, 2023 13:56

Stocks of the Hour: Sayona Mining, Tamboran Resources, Imagion Biosystems

Sayona Mining (ASX:SYA) announced that their preliminary technical study at their NAL lithium carbonate plant study produces an NPV of A$3.2bn. Sayona's Managing Director, Brett Lynch commented: "Sign

sharecafeJun 21, 2023 10:10

Here's Why We're A Bit Worried About Imagion Biosystems' (ASX:IBX) Cash Burn Situation

Yahoo FinanceFeb 7, 2023 08:21